- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1480
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Evaluating drug-drug interaction information in NDF-RT and DrugBank ; volume:6 ; number:1 ; day:11 ; month:5 ; year:2015 ; pages:1-10 ; date:12.2015
Journal of biomedical semantics ; 6, Heft 1 (11.5.2015), 1-10, 12.2015
- Urheber
-
Peters, Lee B.
- Beteiligte Personen und Organisationen
-
Bahr, Nathan
Bodenreider, Olivier
SpringerLink (Online service)
- DOI
-
10.1186/s13326-015-0018-0
- URN
-
urn:nbn:de:101:1-2018070520414592052086
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Peters, Lee B.
- Bahr, Nathan
- Bodenreider, Olivier
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lurasidone drug-drug interaction studies: a comprehensive review
Case report: Medical cannabis—warfarin drug-drug interaction
Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies
Evaluation of a drug-drug interaction: fax alert intervention program
Learning self-supervised molecular representations for drug–drug interaction prediction
On the robustness of generalization of drug–drug interaction models
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels
Targeting continuity of care and polypharmacy to reduce drug–drug interaction
Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases
Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin
A Review of Daclatasvir Drug–Drug Interactions
Lurasidone drug-drug interaction studies: a comprehensive review
Case report: Medical cannabis—warfarin drug-drug interaction
Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies
Evaluation of a drug-drug interaction: fax alert intervention program
Learning self-supervised molecular representations for drug–drug interaction prediction
On the robustness of generalization of drug–drug interaction models
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels
Targeting continuity of care and polypharmacy to reduce drug–drug interaction
Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases
Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin
A Review of Daclatasvir Drug–Drug Interactions
Lurasidone drug-drug interaction studies: a comprehensive review
Case report: Medical cannabis—warfarin drug-drug interaction
Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies
Evaluation of a drug-drug interaction: fax alert intervention program
Learning self-supervised molecular representations for drug–drug interaction prediction
On the robustness of generalization of drug–drug interaction models
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels
Targeting continuity of care and polypharmacy to reduce drug–drug interaction
Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases
Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin